Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 28, 2024 |
| PDB ID | UniProt ID | Title | Descriptor ▲ |
|---|---|---|---|
| 7YJ3 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with human ACE2 (local refinement) | |
| 7YJ3 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with human ACE2 (local refinement) | |
| 7YV8 | A0A1U7QTA1 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with golden hamster ACE2 (local refinement) | |
| 7YV8 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with golden hamster ACE2 (local refinement) | |
| 7YVU | Q8R0I0 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with mouse ACE2 (local refinement) | |
| 7YVU | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with mouse ACE2 (local refinement) | |
| 7ZC9 | Q63HQ2 | Human Pikachurin/EGFLAM C-terminal Laminin-G domain (LG3) | |
| 7ZCB | Q63HQ2 | Human Pikachurin/EGFLAM N-terminal Fibronectin-III (1-2) domains | |
| 8AG1 | P43489 | Crystal structure of a novel OX40 antibody | |
| 8AG1 | 8AG1 | Crystal structure of a novel OX40 antibody | |
| 8B7D | Q9NUM4 | Luminal domain of TMEM106B | |
| 8BW5 | P00734 | X-ray structure of the complex between human alpha thrombin and the duplex/quadruplex aptamer M08s-1_41mer | |
| 8COY | E6Y8B9 | Structure of the catalytic domain of P. vivax Sub1 (triclinic crystal form) in complex with inhibitor | |
| 8COY | 8COY | Structure of the catalytic domain of P. vivax Sub1 (triclinic crystal form) in complex with inhibitor | |
| 8COZ | E6Y8B9 | Structure of the catalytic domain of P. vivax Sub1 (triclinic crystal form) | |
| 8D0Y | 8D0Y | Crystal Structure of HIV-1 BG505 SOSIPv8 Trimer in Complex with CD4bs targeting antibody 21N13 and interface targeting antibody 35O22 at 4.7 Angstrom | |
| 8DNG | Q9IH63 | Prefusion-stabilized Nipah virus fusion protein | |
| 8DNR | O89342 | Prefusion-stabilized Hendra virus fusion protein | |
| 8DOK | A0A140EMT3 | Cryo-EM structure of T/F100 SOSIP.664 HIV-1 Env trimer in complex with 8ANC195 and 10-1074 | |
| 8DOK | A0A6C0ZY47 | Cryo-EM structure of T/F100 SOSIP.664 HIV-1 Env trimer in complex with 8ANC195 and 10-1074 | |
| 8DOK | 8DOK | Cryo-EM structure of T/F100 SOSIP.664 HIV-1 Env trimer in complex with 8ANC195 and 10-1074 | |
| 8DOW | A0A1W6IPB2 | Cryo-EM structure of HIV-1 Env(CH848 10.17 DS.SOSIP_DT) in complex with DH1030.1 Fab | |
| 8DOW | Q2N0S7 | Cryo-EM structure of HIV-1 Env(CH848 10.17 DS.SOSIP_DT) in complex with DH1030.1 Fab | |
| 8DOW | 8DOW | Cryo-EM structure of HIV-1 Env(CH848 10.17 DS.SOSIP_DT) in complex with DH1030.1 Fab | |
| 8DP1 | Q2N0S6 | Cryo-EM structure of HIV-1 Env(BG505.T332N SOSIP) in complex with DH1030.1 Fab | |
| 8DP1 | 8DP1 | Cryo-EM structure of HIV-1 Env(BG505.T332N SOSIP) in complex with DH1030.1 Fab | |
| 8DPL | 8DPL | Structure of EBOV GP lacking the mucin-like domain with 2.1.1D5 scFv and 6D6 scFv bound | |
| 8DPL | Q05320 | Structure of EBOV GP lacking the mucin-like domain with 2.1.1D5 scFv and 6D6 scFv bound | |
| 8DPL | A0A0E3H7K2 | Structure of EBOV GP lacking the mucin-like domain with 2.1.1D5 scFv and 6D6 scFv bound | |
| 8DPM | Q05320 | Structure of EBOV GP lacking the mucin-like domain with 9.20.1A2 Fab and 6D6 scFv bound | |
| 8DPM | A0A0E3H7K2 | Structure of EBOV GP lacking the mucin-like domain with 9.20.1A2 Fab and 6D6 scFv bound | |
| 8DPM | 8DPM | Structure of EBOV GP lacking the mucin-like domain with 9.20.1A2 Fab and 6D6 scFv bound | |
| 8EL2 | P0DTC2 | SARS-CoV-2 RBD bound to neutralizing antibody Fab ICO-hu23 | |
| 8EL2 | 8EL2 | SARS-CoV-2 RBD bound to neutralizing antibody Fab ICO-hu23 | |
| 8ELJ | P0DTC2 | SARS-CoV-2 spike glycoprotein in complex with the ICO-hu23 neutralizing antibody Fab fragment | |
| 8ELJ | 8ELJ | SARS-CoV-2 spike glycoprotein in complex with the ICO-hu23 neutralizing antibody Fab fragment | |
| 8F0M | P01116-2 | Monobody 12D5 bound to KRAS(G12D) | |
| 8F0M | 8F0M | Monobody 12D5 bound to KRAS(G12D) | |
| 8FSJ | 8FSJ | Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520 | |
| 8FSJ | A0A2P0NE34 | Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520 | |
| 8FSJ | 8FSJ | Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520 | |
| 8FSJ | A0A2P0NE34 | Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520 | |
| 8FSJ | A0A2P0NE15 | Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520 | |
| 8FSJ | A0A2P0NE15 | Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520 | |
| 8GRY | Q5EGZ1 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with rat ACE2 (local refinement) | |
| 8GRY | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with rat ACE2 (local refinement) | |
| 8H06 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Omicron BA.4/5 RBD in complex with human ACE2 (local refinement) | |
| 8H06 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Omicron BA.4/5 RBD in complex with human ACE2 (local refinement) | |
| 8H5C | Q9BYF1 | Structure of SARS-CoV-2 Omicron BA.2.75 RBD in complex with human ACE2 | |
| 8H5C | P0DTC2 | Structure of SARS-CoV-2 Omicron BA.2.75 RBD in complex with human ACE2 |
